ACETO Corp (ACET) Misses Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
ACETO Reports Fiscal 2016 Third Quarter Results
May 5, 2016 5:00 PM EDTPORT WASHINGTON, N.Y., May 05, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the third quarter of fiscal 2016 ended March 31, 2016.
Third Quarter Fiscal 2016 versus Third Quarter Fiscal 2015
Net sales of $157.9 million versus $145.8 million, an 8.3% increaseGross profit of $38.3 million versus $36.6 million, a 4.6% increaseNet income of $10.4 million versus $8.4 million, a 23.9% increaseDiluted EPS... MoreACETO Board of Directors Declares Quarterly Cash Dividend
May 5, 2016 11:27 AM EDTPORT WASHINGTON, N.Y., May 05, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ: ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share. This quarterly cash dividend will be distributed on June 24, 2016 to shareholders of record as of June 9, 2016.
ABOUT ACETO
ACETO Corporation, incorporated in 1947 and with offices and operations in 10... More
